Stem cell arthritis study pulled before it began
NCT ID NCT06623240
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study aimed to test whether stem cell infusions could safely improve symptoms in children with juvenile idiopathic arthritis. It was designed for 66 participants aged 2 to 17, but the trial was withdrawn before any patients were enrolled. The main focus was on safety and symptom control, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.